In 2016, we made significant progress in the execution of our strategy and the achievement of our mission to become the premier biopharmaceutical company in the industry by the end of this decade.
Information about Pfizer’s 2016 achievements in Access to Medicines, Top Ten Medicines and Vaccines by Revenue, Colleagues, Progress on Our 2020 Environmental Sustainability Goals and information about our Performance and Financial Guidance.
At Pfizer, our purpose is to bring innovative medicines and vaccines to patients to significantly improve their lives. To ensure we are in the best position to fulfill this commitment, we constantly evaluate how we conduct our commercial enterprise to maximize value for our shareholders.
Read more about Global Businesses
Pfizer Essential Health (PEH) – formerly known as the Global Established Pharma business – is a leader in non-viral anti-infectives, biosimilars and sterile injectable medicines. In emerging markets, the PEH portfolio of affordable, well-known branded medicines makes it a critical partner in the global public health community.
Read more about Pfizer Essential Health
Pfizer Innovative Health (PIH) includes six business groups – Consumer Healthcare, Inflammation & Immunology, Internal Medicine (neuroscience and pain, and cardiovascular and metabolic), Oncology, Rare Disease and Vaccines. Each business group is committed to improving health with our innovative products from prevention to treatment to wellness – at every stage of life in communities across the globe. Our Emerging Markets group is focused on increasing access to Pfizer’s innovative portfolio of medicines to people across developing countries in Latin America, Asia, Africa and the Middle East. And, our Patient and Health Impact group develops solutions for increased patient access, demonstrates the value of our innovations, and ensures broader business model innovation.
Read more about Pfizer Innovative Health
In September 2015, a new era of global development began when the United Nations (UN) officially launched its Sustainable Development Goals (SDGs) to transform our world and "leave no one behind" by 2030. The UN has called for broad-based support of the SDGs, including active involvement by the private sector. To make a significant and sustainable impact, the public and private sectors, as well as civil society stakeholders, are seeking to align activities and work together. Pfizer is committed to helping facilitate industry engagement and align our corporate objectives to accelerate impact for healthy individuals and patients across the globe.
Read case study titled Transforming Delivery of High Quality Products
At Pfizer, we understand that good governance is essential to the success of our business and we conduct ourselves accordingly.
Read more about Governance and Ethics
At Pfizer, we believe that a sustainable future is essential to ensuring the health and well-being of our colleagues, the people who use our products and the communities we touch. By striving for environmental sustainability across all aspects of our organization, we aim to add additional value to society and our business by mitigating climate change and its impact, minimizing the environmental impact of our products and managing water resources.
Read more about Environment, Health and Safety
Pfizer’s global manufacturing and supply operation brings innovative therapies to the patients who need them. Pfizer combines a global footprint – 63 manufacturing sites around the world under Pfizer Global Supply (PGS) – with technologically advanced production and cutting-edge tracking of supply to accelerate patient access. PGS colleagues are dedicated to getting medicines to patients and work closely with our research and development (R&D) partners to develop and deliver quality products that significantly improve patients' lives.
Read more about Manufacturing, Quality and Supply Chain
Information about Pfizer’s Stock Listings, Stock Transfer Agent and Registrar, Shareholder Services and Programs, Political Action Committee (PAC), Helplines as well as Additional Information and Forward-Looking Information.
Read more about Corporate and Shareholder Information
Pfizer's OWNIT! culture empowers all colleagues to be accountable, to foster innovative thinking, to be ready for change and to build collaborative relationships that drive positive business results. We believe our OWNIT! culture also positions Pfizer for long-term success and ensures the growth and development of colleagues.
Biographies of the members of Pfizer’s Board of Directors.
Read more about Board of Directors
Biographies of the members of Pfizer’s Executive Leadership Team.
Read more about Executive Leadership Team
Innovation, inspired by deep consumer insights, underpins the health and wellness solutions we bring to consumers around the world. Whether developing a better way to treat pain, improve nutrition, or enhance vitality and appearance, we look to our consumers to guide the work we do to improve their lives with high-quality, trusted brands.
Read more about Consumer Healthcare
Few words in health care can have such a devastating impact on patients and their families as “cancer.” That motivates us to bring innovative treatments to the forefront and drives us to harness the power of the latest in targeted treatments for our oncology patients.
Pfizer is working to accelerate the development of effective therapies for patients affected by rare diseases, which are often debilitating conditions with exceptionally low prevalence. We are positioned to use our global resources to help address the challenges of living with a rare disease and develop new medicines for those in need, through community partnerships, research and development, robust patient support and educational initiatives.
Every day, we work toward a healthier world by taking on bacterial, viral and infectious diseases that threaten people around the globe. We do this by inventing, developing and championing vaccines, which provide essential health benefits to people of all ages; in other words, Pfizer helps people be “Ready for Life.” We are also progressing and shaping the future of vaccines through investment in research and development (R&D), technology and expanding access to those in need.
The availability of high-quality, biosimilar medicines is expected to play a key role in the future of health care, as they have the potential to expand access to important treatments, provide affordable additional options and help address the evolving needs of patients, physicians and payers. Given the complexity of the development and commercialization of biosimilars, we believe Pfizer’s capabilities – which reflect a strong heritage in the development, manufacturing and commercialization of biologic medicines – position us to succeed as the global leader in the biosimilars marketplace.
Pfizer is advancing disruptive science and accelerating breakthrough therapies with the goal of delivering transformative medicines and vaccines, and the development of potential cures to patients in need.
Clinical trials are the link between investigational medicines and vaccines and the discovery of therapies that impact patients who need them. Pfizer is accelerating innovation in clinical trials by finding ways to make the process more effective and efficient – improving interactions with patients, developing complementary partnerships, and breaking new ground in the use of technology.
Read more about Clinical Trials
There is vast scientific knowledge beyond our walls and collaboration with external experts is a key driver of innovation at Pfizer. There is also a rich and highly networked health ecosystem where multiple organizations are focused on one goal: discover new therapies for patients, as fast as we can.
Read more about Peer Collaboration
The search for novel solutions to unmet health needs drives our scientific development and motivates us to forge unique partnerships. This includes looking beyond traditional health care companies to consider partnerships more broadly. These out-of-the-box collaborations bring together expert thinking from complementary sources to shine light on new perspectives and stimulate progress.
Read case study titled Using the Power of Technology and Innovative Science to Advance Patient Care
Innovation is one of Pfizer’s core values and is central to our business. We add value to health care through our research — taking risks and often making substantial investments — and through our meaningful and deep partnerships with third-party groups. These collaborations allow us to find new ways to prevent and treat diseases, and provide access to and awareness of under recognized therapies and diseases.
Read more about Third-Party Collaboration
Pfizer believes that all individuals deserve access to quality health care and the opportunity to lead healthy lives. We combine creative commercial strategies with philanthropic approaches to create a sustainable and meaningful impact on global health.
Read more about Access to Medicines
At Pfizer, we are committed to helping people age well so they can live a healthy and full life at every step and at any age along the journey. We are accelerating progress against this goal through a wide variety of efforts – forging unique partnerships around the world, creating tools to help raise awareness and measure impact, and supporting the urban environments in which more people are increasingly growing up and growing older.
Read case study titled Bringing Resources to Bear to Improve Global Health
We continue to evolve the way we engage with our patients, caregivers and the health care community around the world. Through various public health initiatives we are working to bridge significant health gaps in patient education and care by arming people with trusted information and tools that enable them to take a more active role in their health care.
Read case study titled Partnering to Tackle Non-Communicable Diseases